gilead

This is Why Amgen is Soaring

By Ben LevisohnInvestors love biotech stocks, but heading into July, Amgen (AMGN) was unloved, especially compared to its other biotech giants like Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD) and Biogen (BIIB). No longer. Shares of Amgen have jumped nearly 6% after reporting better than forecast earnings and raising its guidance. UBS analyst Matthew Roden has the details:
Amgen reported another strong […]

FED Rallies Market But Biotech Stocks Are Lagging

Market Rallies on FED comments but Biotechs are Left Behind
FED Expected to Raise Rates as Labor Market Tightens
The FED stands pat on rates but is on track to raise rates later this year, possibly at the September meeting, as jobs are on track but inflation is still not above 2%. The market began rally at 2P EDT after the FED […]

Biotech Stocks To Keep Your Eye On | Gilead Sciences (GILD) | BG …

Markets are rebounding today after a horrible beginning to the week. Looking in the biotech sector, I’m seeing a sea of green with very few blemishes. I’ve also been able to dig out a few great opportunities in the sector. Here they are…Gilead Sciences Is Likely To See Long Run GainsGilead Sciences, Inc. (NASDAQ: GILD)I’ve talked about Gilead Sciences quite […]

Gilead Sciences, Inc. (GILD) Stock Update

Gilead Sciences, Inc. (GILD) Stock Update by Bidness ETC : Wednesday 11:44:23 CTCategories: News, streamGilead Sciences, Inc. (NASDAQ:GILD) has had an unimpressive month so far, which is unusual for a stock that happens to be one of the most traded biotech stocks in the market. The company’s stock has actually traded down 1.67% since the beginning of July, reaching a […]

A Sector Immune to Greece

“By declaring Greece in arrears, the IMF avoided using the term ‘default,’” says this morning’s New York Times.If you read yesterday’s 5 Minute Forecast, you already knew that’s what would happen. The Greek government missed a $1.7 billion payment to the International Monetary Fund. But don’t call it a default.The U.S. finance industry played this game a few years ago. […]

Biotech to break out, buy these names: Analyst – CNBC.com

While the stocks are not cheap, they’re not expensive, he added. What investors are paying for is high quality growth and high quality earnings.Read MoreCramer: Secret pattern to unlocking biotech richesIn fact, he thinks people have underappreciated biotech’s “fantastic” margins, noting that the companies now have 50 to 70 percent operating margins and “tons of real cash flow.””These are real […]

The One Biotech Stock That Looks Like a Bargain These Days

Over the course of this long bull market, biotech stocks have been very, very good for their owners. Perhaps too good. Investors have shown such rabid enthusiasm for biotechs—especially small, unproven companies that have yet to bring a drug to market—that some observers are using another b word to describe the high-flying sector: bubble.See Also: 8 Stocks Under $10 Worth […]

Why Smart Money Loves This Biotech Stock

Source: Amgen, Flickr.The biotech sector is something of a roulette wheel for investors. The chances of being right are typically against you, but if you can land a winner every now and then the rewards can multiply many times over your initial bet.A majority of the biotech sector is comprised of clinical-stage pipelines or developing product portfolios which are still […]

The biotech sector looks an awful lot like a bubble

View gallery.(Wikimedia Commons)There is probably a bubble in biotech stocks. 
In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what […]

David Stockman; Why Yellen And The Feds Are Bubble Blind, They Apparently Believe Wall Street’s EPS Scam

Surveying the Fed’s handiwork during last week’s press conference, Janet Yellen noted that all was awesome except that stocks were now slightly “on the high side” of their historical range. You can say that again! In fact, you can say that any one capable of uttering such tommyrot has been totally bamboozled by Wall Street’s sell-side con artists. Yes, the […]